LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that the company will release financial results for the third quarter of 2008, which ended September 30, 2008, before the market opens on Tuesday, November 4, 2008. Elkan Gamzu, Ph.D., interim chief executive officer, and Kim Drapkin, chief financial officer, will host a conference call and webcast at 10:00 a.m. (EDT) on Tuesday, November 4, 2008 to discuss the company's financial results, recent accomplishments and progress toward 2008 goals.
